Creatine transporter expression after antidepressant therapy in rats bred for learned helplessness

World Journal of Biological Psychiatry

Volumn 11, Issue 2 PART 2, 2010, Pages 329-333

  Lugenbiel, Patrick ^a   Sartorius, Alexander ^a   Vollmayr, Barbara ^a   Schloss, Patrick ^a  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

Antidepressive treatment; Creatine transporter; ECS; Hippocampus; Learned helplessness; Prefrontal cortex

Indexed keywords

BETA ACTIN; CARRIER PROTEIN; CREATINE; CREATINE TRANSPORTER; DESIPRAMINE; ESCITALOPRAM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; ELECTROCONVULSIVE THERAPY; HIPPOCAMPUS; LEARNED HELPLESSNESS; MALE; NONHUMAN; PREFRONTAL CORTEX; PROTEIN EXPRESSION; RAT;

ACTINS; ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CITALOPRAM; FEMALE; GENE EXPRESSION; HELPLESSNESS, LEARNED; HIPPOCAMPUS; MALE; MEMBRANE TRANSPORT PROTEINS; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY;

EID: 77950822812     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622970903131597     Document Type: Article

References (30)

1. Braissant O, Henry H, Loup M, Eilers B, Bachmann C. 2001. Endogenous synthesis and transport of creatine in the rat brain: an in situ hybridization study. Brain Res Mol Brain Res 86 (1-2):193-201.
2. Cecil KM, Salomons GS, Ball WS, Jr., Wong B, Chuck G, Verhoeven NM, et al. 2001. Irreversible brain creatine deficiency with elevated serum and urine creatine: a creatine transporter defect? Ann Neurol 49(3):401-404.
3. Czeh B, Michaelis T, Watanabe T, Frahm J, de Biurrun G, van Kampen M, et al. 2001. Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc Natl Acad Sci USA 98(22):12796-12801.
4. Dechent P, Pouwels PJ, Wilken B, Hanefeld F, Frahm J. 1999. Increase of total creatine in human brain after oral supplementation of creatine- monohydrate. Am J Physiol 277(3 Pt 2):R698-704.
5. Ende G, Braus DF, Walter S, Weber-Fahr W, Henn FA. 2000. The hippocampus in patients treated with electroconvulsive therapy: a proton magnetic resonance spectroscopic imaging study. Arch Gen Psychiatry 57(10):937-943.
6. Gall C, Lauterborn J, Bundman M, Murray K, Isackson P. 1991. Seizures and the regulation of neurotrophic factor and neuropeptide gene expression in brain. Epilepsy Res Suppl 4: 225-245.
7. Henn FA, Vollmayr B. 2005. Stress models of depression: forming genetically vulnerable strains. Neurosci Biobehav Rev 29(4- 5):799-804.
8. Klerman GL, Weissman MM. 1992. The course, morbidity, and costs of depression. Arch Gen Psychiatry 49(10):831-834.
9. Kozisek ME, Deupree JD, Burke WJ, Bylund DB. 2007. Appropriate dosing regimens for treating juvenile rats with desipramine for neuropharmacological and behavioral studies. J Neurosci Methods 163(1):83-91.
10. Larsen MH, Hay-Schmidt A, Ronn LC, Mikkelsen JD. 2008. Temporal expression of brain-derived neurotrophic factor (BDNF) mRNA in the rat hippocampus after treatment with selective and mixed monoaminergic antidepressants. Eur J Pharmacol 578(2-3):114-122. (Pubitemid 350309578)
11. Madsen TM, Treschow A, Bengzon J, Bolwig TG, Lindvall O, Tingstrom A. 2000. Increased neurogenesis in a model of electroconvulsive therapy. Biol Psychiatry 47(12):1043-1049. (Pubitemid 30336212)
12. Rajkowska G, Miguel-Hidalgo JJ. 2007. Gliogenesis and glial pathology in depression. CNS Neurol Disord Drug Targets 6(3):219-233. (Pubitemid 46916253)
13. Rosenberg EH, Almeida LS, Kleefstra T, deGrauw RS, Yntema HG, Bahi N, et al. 2004. High prevalence of SLC6A8 deficiency in X-linked mental retardation. Am J Hum Genet 75(1):97-105. (Pubitemid 38801905)
14. Sanchez C, Bergqvist PB, Brennum LT, Gupta S, Hogg S, Larsen A, et al. 2003. Escitalopram, the S-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities. Psychopharmacology (Berlin) 167(4): 353-362. (Pubitemid 36754236)
15. Sartorius A, Vollmayr B, Neumann-Haefelin C, Ende G, Hoehn M, Henn FA. 2003. Specific creatine rise in learned helplessness induced by electroconvulsive shock treatment. Neuroreport 14(17):2199-2201. (Pubitemid 36385064)
16. Sartorius A, Mahlstedt MM, Vollmayr B, Henn FA, Ende G. 2007. Elevated spectroscopic glutamate/gamma-amino butyric acid in rats bred for learned helplessness. Neuroreport 18(14):1469-1473. (Pubitemid 47295947)
17. Sartorius A, Lugenbiel P, Mahlstedt MM, Ende G, Schloss P, Vollmayr B. 2008. Proton magnetic resonance spectroscopic creatine correlates with creatine transporter protein density in rat brain. J Neurosci Methods 172(2):215-219.
18. Schloss P, Henn FA. 2004. New insights into the mechanisms of antidepressant therapy. Pharmacol Ther 102(1):47-60. (Pubitemid 38429985)
19. Schloss P, Mayser W, Betz H. 1994. The putative rat choline transporter CHOT1 transports creatine and is highly expressed in neural and muscle-rich tissues. Biochem Biophys Res Commun 198(2):637-645. (Pubitemid 24178416)
20. Schulze A, Bachert P, Schlemmer H, Harting I, Polster T, Salomons GS, et al. 2003. Lack of creatine in muscle and brain in an adult with GAMT deficiency. Ann Neurol 53(2):248-251. (Pubitemid 36164008)
21. Speer O, Neukomm LJ, Murphy RM, Zanolla E, Schlattner U, Henry H, et al. 2004. Creatine transporters: a reappraisal. Mol Cell Biochem 256-257(1-2):407-424. (Pubitemid 38181262)
22. Sykut-Cegielska J, Gradowska W, Mercimek-Mahmutoglu S, Stockler-Ipsiroglu S. 2004. Biochemical and clinical characteristics of creatine deficiency syndromes. Acta Biochim Pol 51(4):875-882. (Pubitemid 40187559)
23. Tachikawa M, Fukaya M, Terasaki T, Ohtsuki S, Watanabe M. 2004. Distinct cellular expressions of creatine synthetic enzyme GAMT and creatine kinases uCK-Mi and CK-B suggest a novel neuron-glial relationship for brain energy homeostasis. Eur J Neurosci 20(1):144-160. (Pubitemid 38932135)
24. Vaidya VA, Terwilliger RZ, Duman RS. 2000. Alterations in heavy and light neurofilament proteins in hippocampus following chronic ECS administration. Synapse 35(2):137-143.
25. Videbech P, Ravnkilde B. 2004. Hippocampal volume and depression: a meta-analysis of MRI studies. Am J Psychiatry 161(11):1957-1966. (Pubitemid 39441394)
26. Videbech P, Ravnkilde B, Pedersen TH, Hartvig H, Egander A, Clemmensen K, et al. 2002. The Danish PET/depression project: clinical symptoms and cerebral blood flow. A regionsof-interest analysis. Acta Psychiatr Scand 106(1):35-44.
27. Vollmayr B, Henn FA. 2001. Learned helplessness in the rat: improvements in validity and reliability. Brain Res Brain Res Protoc 8(1):1-7. (Pubitemid 32777872)
28. Walzel B, Speer O, Boehm E, Kristiansen S, Chan S, Clarke K, et al. 2002. New creatine transporter assay and identification of distinct creatine transporter isoforms in muscle. Am J Physiol Endocrinol Metab 283(2):E390-401.
29. Wieronska JM, Klak K, Palucha A, Branski P, Pilc A. 2007. Citalopram influences mGlu7, but not mGlu4 receptors' expression in the rat brain hippocampus and cortex. Brain Res 1184:88-95.
30. Zink M, Rapp S, Gebicke-Haerter PJ, Henn FA, Thome J. 2005. Antidepressants differentially affect expression of complexin I and II RNA in rat hippocampus. Psychopharmacology (Berlin) 181(3):560-565.